Share:
Peer-Reviewed Publication
JACC Adv2023;2(1):100166.January 1, 2023Editorial

Machine Learning Algorithms: Selection of Appropriate Validation Populations for Cardiology Research-Be Careful!

William E Sanders1, Rola Khedraki2, Mark Rabbat3, Thomas R McMinn4, Tim Burton5, Ali Khosousi5, Farhad Fathieh5, Horace R Gillins6, Shyam Ramchandani5, Ian P Shadforth6
1CorVista Health, Inc, Washington, DC, USA; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Electronic address: wsanders@corvista.com.
2Scripps Clinic, San Diego, California, USA.
3Loyola University Medical Center, Maywood, Illinois, USA.
4Austin Heart, Austin, Texas, USA.
5CorVista Health(†), Toronto, Ontario, Canada.
6CorVista Health, Inc, Washington, DC, USA.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.